A critical advance in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This crucial tumor suppressor protein is frequently disabled in many types of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research